LEAH Labs

Cell & Gene Therapy · Health Care
$1.9Mraised in 4 rounds
1backers · Y Combinator
$1.9Mgrants · 4 grants · CORDIS
10+team · employees, estimated range

Overview

Designer cell therapies for pets first and their people next.

Funding and backers

Team
11-50
employees, estimated range
Grants
$1.9M
4 grants · CORDIS
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 4, 2025 Won a grant $400k · CORDIS Oct 1, 2023 Won a grant $974k · CORDIS Mar 1, 2022 Won a grant $337k · CORDIS Jun 1, 2020 Won a grant $225k · CORDIS Jan 2019 Went through Y Combinator 2018 Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Grant Aug 2025 $400k — CORDIS
Grant Oct 2023 $974k — CORDIS
Grant Mar 2022 $337k — CORDIS
Grant Jun 2020 $225k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity LifEngine Animal Health Laboratories Incorporated SEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator W19 accelerator
Investors in similar startupsfunds that back the companies most like this one
Andreessen Horowitz
backs GC Therapeutics (Copy)
General Catalyst
backs Waypoint Bio
Global Brain
backs GC Therapeutics (Copy)
Hummingbird Ventures
backs Waypoint Bio
Horizons Ventures
backs Kytopen
Helmholtz
backs CARTemis Therapeutics GmbH
Similar startupsby what they do, their industry and backers
MediSix Therapeutics
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
Waypoint Bio11-50 employees
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Calycia Bioscience
Pioneering Cell Therapies for the Central Nervous System. We are a Salt Lake City-based biotechnology company developing novel macrophage…
CARTemis Therapeutics GmbH
Next-generation CAR T-cell therapies engineered to disrupt the tumor microenvironment OUR MISSION CARTemis Therapeutics is a clinical-stage…
KytopenVenture round $7.1M · 21 mo ago · Founded 2017 · 51-200 employees
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing…
Vitro BiopharmaVenture round $100k · 17 mo ago · 11-50 employees
Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases…

Financials

Total raised
$1.9M
Latest round
Grant
Funding rounds
4
Funding rounds
Round Announced Amount
Grant 2025 $400k Details
Grant 2023 $974k Details
Grant 2022 $337k Details
Grant 2020 $225k Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Y CombinatorVia a fund
6310 portfolio companies
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Minneapolis United States
HQ
10-50 est. staff